Skip to content
NMN Human Trials
Human Study: Liposomal NMN More Effective
Scientific Evidence Library
Inhibition of CD38 Increases NAD+ Levels, ...
Two recent studies have found that inhibition of CD38 (with 78c or PCC1) increase NAD+ levels and result in significant increases in lifespan and healthspan in mice.
Inhibition of CD38 Increases NAD+ Levels, Exten...
Two recent studies have found that inhibition of CD38 (with 78c or PCC1) increase NAD+ levels...
Inhibition of CD38 Increases NAD+ Levels
Inhibition of CD38 Increases NAD+ and Extends Lifespan and Healthspan Two recent studies have found that inhibition of CD38 (with 78c or PCC1) increase NAD+ levels and result in significant...
Inhibition of CD38 Increases NAD+ Levels
Inhibition of CD38 Increases NAD+ and Extends Lifespan and Healthspan Two recent studies have found that...
Study Shows NMN Supplementation or CD38 In...
Declining NAD+ levels are a major contributor to cardiovascular disease in mice. It was demonstrated that raising NAD+ levels through NMN supplementation or by CD38 inhibition can restore cardiovascular function...
Study Shows NMN Supplementation or CD38 Inhibit...
Declining NAD+ levels are a major contributor to cardiovascular disease in mice. It was demonstrated that...